<DOC>
	<DOC>NCT00042432</DOC>
	<brief_summary>This study will assess an investigational medication for patients with chronic renal insufficiency (pre-dialysis) who have secondary hyperparathyroidism.</brief_summary>
	<brief_title>Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Hyperparathyroidism, Secondary</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Cinacalcet Hydrochloride</mesh_term>
	<criteria>Patients must have chronic renal insufficiency (predialysis) Have below normal creatinine clearance Have elevated parathyroid hormone levels Pregnant or nursing Heart attack in the last 3 months.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>